The PDS Biotechnology Story

When: Wednesday, February 13, 2013 at 5:30 pm
Where: SH 335
Speaker: Dr. Frank Bedu-Addo
Organization: President and CEO, PDS Biotechnology Corporation
Sponsor: IGERT Nanomedicine Science & Technology

Frank Bedu-Addo is the President and CEO of PDS Biotechnology Corporation. Frank has extensive business experience developing operational strategy, overseeing operations and managing profit and loss. He was most recently on the senior executive management team of KBI BioPharma in RTP, NC, where he started up the company’s operations, provided steady double digit revenue growth, and established a current and growing industry-leading contract biotech drug development company. Prior to KBI, Bedu-Addo also successfully started up and managed Cardinal Health’s East Coast biotech drug development operations.

This is a new series of seminars examining the commercialization of nanotechnology, biotechnology and nanomedicine-based R&D from concept to market. Distinguished guest speakers include venture capitalists, entrepreneurs, and regulatory officials.

The seminars are coordinated with a new course NNMD5470 Nanotechnology and Nanomedicine Product Development: From Concept To Market being taught in Spring 2013.

http://www.igert.neu.edu/courses.htm